Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallgeir Rui

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
The American Journal of Pathology|October 19, 2010
PTP1B suppresses prolactin activation of Stat5 in breast cancer cellsKevin J Johnson, Amy R Peck, Chengbao Liu, et al.
Cell Reports|December 17, 2025
STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ductsRayane Dennaoui, Madison N Wicker, Carson Moen, et al.
Cancer Biology & Therapy|May 8, 2020
Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancersOlena Odnokoz, Pengfei Yu, Amy R Peck, et al.
Cancer Biology & Therapy|June 9, 2009
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancerAgnieszka K Witkiewicz, Abhijit Dasgupta, Katherine H Nguyen, et al.
The American Journal of Pathology|October 31, 2006
Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cellsTerence M Williams, Federica Sotgia, Hyangkyu Lee, et al.
Oncogene|August 19, 2020
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesisChristina Cho, Riddhita Mukherjee, Amy R Peck, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2014
The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancerChantell Wilson, Jieru E Lin, Peng Li, et al.
Iscience|September 4, 2023
Machine learning reveals genetic modifiers of the immune microenvironment of cancerBridget Riley-Gillis, Shirng-Wern Tsaih, Emily King, et al.
Journal of Personalized Medicine|May 25, 2024
Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast CancerJulie M Jorns, Yunguang Sun, Sailaja Kamaraju, et al.
Nature Communications|June 19, 2021
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cellsPatrick D Rädler, Barbara L Wehde, Aleata A Triplett, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
The American Journal of Pathology|October 19, 2010
PTP1B suppresses prolactin activation of Stat5 in breast cancer cellsKevin J Johnson, Amy R Peck, Chengbao Liu, et al.
Cell Reports|December 17, 2025
STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ductsRayane Dennaoui, Madison N Wicker, Carson Moen, et al.
Cancer Biology & Therapy|May 8, 2020
Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancersOlena Odnokoz, Pengfei Yu, Amy R Peck, et al.
Cancer Biology & Therapy|June 9, 2009
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancerAgnieszka K Witkiewicz, Abhijit Dasgupta, Katherine H Nguyen, et al.
The American Journal of Pathology|October 31, 2006
Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cellsTerence M Williams, Federica Sotgia, Hyangkyu Lee, et al.
Oncogene|August 19, 2020
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesisChristina Cho, Riddhita Mukherjee, Amy R Peck, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2014
The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancerChantell Wilson, Jieru E Lin, Peng Li, et al.
Iscience|September 4, 2023
Machine learning reveals genetic modifiers of the immune microenvironment of cancerBridget Riley-Gillis, Shirng-Wern Tsaih, Emily King, et al.
Journal of Personalized Medicine|May 25, 2024
Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast CancerJulie M Jorns, Yunguang Sun, Sailaja Kamaraju, et al.
Nature Communications|June 19, 2021
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cellsPatrick D Rädler, Barbara L Wehde, Aleata A Triplett, et al.
Pageof 14